Clinical Trial Update: Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating anakinra for efficacy in patients with rheumatoid arthritis and type 2 diabetes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis Rheumatoid
• Type 2 Diabetes Mellitus

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Prof. Roberto Giacomelli | Conditions: Diabetes Mellitus, Type 2, Arthritis, Rheumatoid | Phase 4 | Status: TERMINATED